Our new findings were consistent with recent studies, which have shown a correlation between MAP4 overexpression and poorer prognostic outcome in bladder cancer and esophageal squamous cell carcinoma [18, 19]. This evidence concerns the gene MAP4 and urinary bladder cancer.